Cargando…
Passive Monoclonal and Polyclonal Antibody Therapies
Passive antibody therapies have a long history of use. In the 19th century, antibodies from xenographic sources of polyclonal antibodies were used to treat infections (diphtheria). They were used often as protection from infectious agents and toxins. Complications related to their use involved devel...
Autores principales: | Pelletier, J. Peter R., Mukhtar, Faisal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153350/ http://dx.doi.org/10.1016/B978-0-323-67509-3.00016-0 |
Ejemplares similares
-
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023) -
Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin
por: Farahi, Lia, et al.
Publicado: (2019) -
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
por: Berry, Jody D., et al.
Publicado: (2011) -
Production and application of polyclonal and monoclonal antibodies against Spiroplasma eriocheiris
por: Zhang, Ying, et al.
Publicado: (2015) -
Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)